Adrenal carcinoma historical perspective: Difference between revisions
Jump to navigation
Jump to search
Homa Najafi (talk | contribs) No edit summary |
Homa Najafi (talk | contribs) |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Adrenal carcinoma}} | {{Adrenal carcinoma}} | ||
{{CMG}}; {{AE}} {{Homa}} | {{CMG}}; {{AE}} {{Homa}} | ||
Line 21: | Line 19: | ||
===Impact on Cultural History=== | ===Impact on Cultural History=== | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Disease]] | [[Category:Disease]] |
Latest revision as of 18:39, 7 February 2019
Adrenal Carcinoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Adrenal carcinoma historical perspective On the Web |
American Roentgen Ray Society Images of Adrenal carcinoma historical perspective |
Risk calculators and risk factors for Adrenal carcinoma historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]
Overview
Historical Perspective
Discovery
- There is limited information about the historical perspective of [disease name].
OR
- [Disease name] was first discovered by [name of scientist], a [nationality + occupation], in [year]/during/following [event].
- The association between [important risk factor/cause] and [disease name] was made in/during [year/event].
- In [year], [scientist] was the first to discover the association between [risk factor] and the development of [disease name].
- In [year], [gene] mutations were first implicated in the pathogenesis of [disease name].